Shifeng LIU

Person

Hangzhou, Zhejiang, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Highly active CSF1R inhibitor compound
- Patent number 11,591,328
- Issue date Feb 28, 2023
- XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
- Shifeng Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compound serving as FGFR4 inhibitor
- Patent number 11,352,353
- Issue date Jun 7, 2022
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocycles useful as anti-cancer agents
- Patent number 11,225,492
- Issue date Jan 18, 2022
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor
- Patent number 11,142,535
- Issue date Oct 12, 2021
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound containing tricyclic heteroaryl group
- Patent number 10,968,234
- Issue date Apr 6, 2021
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compound used as FGFR inhibitor
- Patent number 10,934,311
- Issue date Mar 2, 2021
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound containing tricyclic heteroaryl group
- Patent number 10,730,887
- Issue date Aug 4, 2020
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocycles useful as IDO and TDO inhibitors
- Patent number 10,358,451
- Issue date Jul 23, 2019
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ADENOSINE RECEPTOR ANTAGONIST
- Publication number 20220339160
- Publication date Oct 27, 2022
- XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
- Zhiyong YU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADENOSINE RECEPTOR ANTAGONIST
- Publication number 20220267350
- Publication date Aug 25, 2022
- XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
- Zhiyong YU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HIGHLY ACTIVE CSF1R INHIBITOR COMPOUND
- Publication number 20200399265
- Publication date Dec 24, 2020
- ADLAI NORTYE BIOPHARMA CO., LTD.
- Shifeng LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND CONTAINING TRICYCLIC HETEROARYL GROUP
- Publication number 20200354376
- Publication date Nov 12, 2020
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUND SERVING AS FGFR4 INHIBITOR
- Publication number 20200199120
- Publication date Jun 25, 2020
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUND AS SYK INHIBITOR AND/OR SYK-HDAC DUAL INHIBITOR
- Publication number 20200079795
- Publication date Mar 12, 2020
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND CONTAINING TRICYCLIC HETEROARYL GROUP
- Publication number 20190308993
- Publication date Oct 10, 2019
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUND USED AS FGFR INHIBITOR
- Publication number 20190100531
- Publication date Apr 4, 2019
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLES USEFUL AS ANTI-CANCER AGENTS
- Publication number 20180370991
- Publication date Dec 27, 2018
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLES USEFUL AS IDO AND TDO INHIBITORS
- Publication number 20180127418
- Publication date May 10, 2018
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Shifeng LIU

Person

Patents Grantslast 30 patents

Highly active CSF1R inhibitor compound

Heterocyclic compound serving as FGFR4 inhibitor

Heterocycles useful as anti-cancer agents

Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor

Compound containing tricyclic heteroaryl group

Heterocyclic compound used as FGFR inhibitor

Compound containing tricyclic heteroaryl group

Heterocycles useful as IDO and TDO inhibitors

Patents Applicationslast 30 patents

ADENOSINE RECEPTOR ANTAGONIST

ADENOSINE RECEPTOR ANTAGONIST

HIGHLY ACTIVE CSF1R INHIBITOR COMPOUND

COMPOUND CONTAINING TRICYCLIC HETEROARYL GROUP

HETEROCYCLIC COMPOUND SERVING AS FGFR4 INHIBITOR

HETEROCYCLIC COMPOUND AS SYK INHIBITOR AND/OR SYK-HDAC DUAL INHIBITOR

COMPOUND CONTAINING TRICYCLIC HETEROARYL GROUP

HETEROCYCLIC COMPOUND USED AS FGFR INHIBITOR

HETEROCYCLES USEFUL AS ANTI-CANCER AGENTS

HETEROCYCLES USEFUL AS IDO AND TDO INHIBITORS